New eye drug AVT29 takes on eylea HD in DME trial
Disease control
Recruiting now
This study tests a new medicine called AVT29 against an approved drug, Eylea HD, for people with diabetic macular edema (DME), a leading cause of vision loss in diabetes. About 256 adults with DME will receive either AVT29 or Eylea HD to see if AVT29 works just as well at improvi…
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC